title: Safety, pharmacokinetic, and pharmacodynamic evaluations of PI-2301, a potent immunomodulator, in a first-in-human, single-ascending-dose study in healthy volunteers.
authors.affiliation: Peptimmune, Inc, 64 Sidney Street, Suite 380, Cambridge, MA 02139, USA.
authors.forename: Joseph
authors.initials: J
authors.lastname: Kovalchin
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Krieger
authors.forename: Kathy
authors.initials: K
authors.lastname: Collins
authors.forename: Michelle
authors.initials: M
authors.lastname: Genova
authors.forename: Michael
authors.initials: M
authors.lastname: Augustyniak
authors.forename: Allyson
authors.initials: A
authors.lastname: Masci
authors.forename: Tony
authors.initials: T
authors.lastname: Avril
authors.forename: Gwenola
authors.initials: G
authors.lastname: Gandon
authors.forename: Alain
authors.initials: A
authors.lastname: Patat
authors.forename: Nicolas
authors.initials: N
authors.lastname: Fauchoux
authors.forename: Claire
authors.initials: C
authors.lastname: Toutin
authors.forename: Eric
authors.initials: E
authors.lastname: Lacoste
authors.forename: Uday
authors.initials: U
authors.lastname: Patel
authors.forename: Edward
authors.initials: E
authors.lastname: Mascioli
authors.forename: Eric
authors.initials: E
authors.lastname: Zanelli